To the full analysis
Buyback calculator for NRC Health
NRC Health stock: key metrics
NRCNRC Health had an operating margin of 16.4% and a return on invested capital (ROIC) of 16.3% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 55.6% | 22.6% | 13.4% |
| 2007 | 55.4% | 23.2% | 14.0% |
| 2008 | 53.7% | 23.5% | 14.6% |
| 2009 | 57.4% | 23.7% | 14.7% |
| 2010 | 61.1% | 21.9% | 13.4% |
| 2011 | 62.2% | 24.7% | 15.3% |
| 2012 | 59.0% | 26.3% | 17.4% |
| 2013 | 58.0% | 26.8% | 16.7% |
| 2014 | 57.8% | 28.6% | 18.4% |
| 2015 | 56.4% | 25.8% | 17.2% |
| 2016 | 58.3% | 28.5% | 18.8% |
| 2017 | 58.3% | 29.1% | 19.5% |
| 2018 | 60.2% | 29.5% | 25.1% |
| 2019 | 63.7% | 33.6% | 25.3% |
| 2020 | 63.1% | 32.0% | 28.0% |
| 2021 | 64.6% | 34.0% | 25.3% |
| 2022 | 62.4% | 30.7% | 21.0% |
| 2023 | 62.3% | 27.0% | 20.8% |
| 2024 | 60.2% | 24.6% | 17.3% |
| 2025 | 56.3% | 16.4% | 8.4% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | 16.0% | 13.4% | 9.6% |
| 2007 | 16.2% | 15.9% | 11.1% |
| 2008 | 19.3% | 17.8% | 10.5% |
| 2009 | 19.2% | 21.0% | 11.7% |
| 2010 | 17.5% | 19.8% | 8.9% |
| 2011 | 20.8% | 21.8% | 11.5% |
| 2012 | 26.6% | 24.9% | 15.1% |
| 2013 | 21.6% | 27.7% | 14.0% |
| 2014 | 20.7% | 35.9% | 14.0% |
| 2015 | 23.7% | 40.3% | 13.6% |
| 2016 | 24.8% | 47.0% | 17.0% |
| 2017 | 25.5% | 42.1% | 18.0% |
| 2018 | 157.5% | 92.3% | 27.9% |
| 2019 | 98.5% | 104.7% | 29.3% |
| 2020 | 57.9% | 64.5% | 27.9% |
| 2021 | 43.9% | 63.2% | 23.8% |
| 2022 | 44.1% | 53.2% | 24.4% |
| 2023 | 63.3% | 40.9% | 25.3% |
| 2024 | 79.2% | 30.9% | 18.7% |
| 2025 | 82.9% | 16.3% | 8.6% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Oct 2023)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.